QUEST DIAGNOSTICS INCORPORATED

Lobbying for QUEST DIAGNOSTICS INCORPORATED

Filing 1st Quarter - Amendment

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Jan 20, 2026

Expenses

$330,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 6363
Further Continuing Appropriations and Other Extensions Act, 2024

Lobbying activity 3

Health Issues

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation

Medicare/Medicaid

P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

Budget/Appropriations

FY 2026 appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.